# Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00876694** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 186 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** Indacaterol 300 µg
- **DRUG:** Salmeterol 50 µg

## Key facts

- **NCT ID:** NCT00876694
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2011-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00876694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00876694, "Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00876694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*